Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ARTNA | Taylor Dian C | Director | 08/31/2026 | Verkauf | 35.50 | 2,000 | 71,000 | Form 4 |
| ABR | Green William C | Director | 08/31/2026 | Kauf | 5.10 | 16 | 82 | Form 4 |
| ABR | Green William C | Director | 08/31/2026 | Kauf | 5.09 | 950 | 4,836 | Form 4 |
| ABR | Green William C | Director | 08/31/2026 | Kauf | 5.07 | 24,985 | 126,674 | Form 4 |
| ANIP | Carey Stephen P. | SVP & CFO | 08/31/2026 | Verkauf | 72.80 | 2,850 | 207,480 | Form 4 |
| ATLO | Cassabaum Michelle R | Director | 08/31/2026 | Kauf | 31.54 | 180 | 5,677 | Form 4 |
| AGNT | Weakley Monica | Director | 08/31/2026 | Optionsausübung | — | 11 | — | Form 4 |
| AGNT | Weakley Monica | Director | 08/31/2026 | Zuteilung | 3.85 | 521 | 2,006 | Form 4 |
| ASTE | Hartley Chad Jeffrey | Group President | 08/28/2026 | Zuteilung | — | 38 | — | Form 4 |
| ASTE | Putney Robert Gerald | VP, Chief Accounting Officer | 08/28/2026 | Zuteilung | — | 3 | — | Form 4 |
| ASTE | Gilbert Edward Terrell Jr | GC & CORPORATE SECRETARY | 08/28/2026 | Zuteilung | — | 22 | — | Form 4 |
| ASTE | Norris Michael Paul | GROUP PRESIDENT | 08/28/2026 | Zuteilung | — | 23 | — | Form 4 |
| ASTE | Winford James Murphy Jr | Director | 08/28/2026 | Zuteilung | — | 7 | — | Form 4 |
| ASTE | Knoll Linda I. | Director | 08/28/2026 | Zuteilung | — | 7 | — | Form 4 |
| ASTE | Jain Nalin | Director | 08/28/2026 | Zuteilung | — | 7 | — | Form 4 |
| ASTE | Cook Tracey H | Director | 08/28/2026 | Zuteilung | — | 18 | — | Form 4 |
| ASTE | Merwe Jaco van der | Chief Executive Officer | 08/28/2026 | Zuteilung | — | 139 | — | Form 4 |
| ASTE | Harris Brian James | Chief Financial Officer | 08/28/2026 | Zuteilung | — | 37 | — | Form 4 |
| ASTE | Shannon Patrick S | Director | 08/28/2026 | Zuteilung | — | 18 | — | Form 4 |
| ASTE | Jackson Jeffrey T | Director | 08/28/2026 | Zuteilung | — | 25 | — | Form 4 |
| ASTE | Gliebe Mark Joseph | Director | 08/28/2026 | Zuteilung | — | 7 | — | Form 4 |
| ASTE | Howell Mary L | Director | 08/28/2026 | Zuteilung | — | 7 | — | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/28/2026 | Verkauf | 20.00 | 679 | 13,580 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/28/2026 | Optionsausübung | 8.04 | 679 | 5,459 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Wandlung | 84.98 | 1,000 | 84,977 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Wandlung | 83.94 | 2,497 | 209,607 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Wandlung | 83.43 | 17,118 | 1,428,126 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Wandlung | 82.58 | 10,385 | 857,609 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Verkauf | 87.47 | 103,589 | 9,060,640 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Verkauf | 86.50 | 8,201 | 709,418 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Verkauf | 85.29 | 36,300 | 3,095,864 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Verkauf | 84.42 | 9,410 | 794,345 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Kauf | 89.36 | 126,000 | 11,259,360 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Kauf | 84.32 | 38,430 | 3,240,322 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Kauf | 83.58 | 61,552 | 5,144,652 | Form 4 |
| AUGO | Sousa Mauad Bruno | Director | 08/28/2026 | Kauf | 82.57 | 26,018 | 2,148,418 | Form 4 |
| AIP | Cantwell Wayne C | Director | 08/28/2026 | Optionsausübung | 0.60 | 5,000 | 3,000 | Form 4 |
| ANET | Duda Kenneth | President and CTO | 08/28/2026 | J | — | 102,320 | — | Form 4 |
| ANET | Duda Kenneth | President and CTO | 08/28/2026 | J | — | 42,938 | — | Form 4 |
| ANET | Duda Kenneth | President and CTO | 08/28/2026 | J | — | 42,937 | — | Form 4 |
| ANET | Duda Kenneth | President and CTO | 08/28/2026 | J | — | 51,160 | — | Form 4 |
| ANET | Duda Kenneth | President and CTO | 08/28/2026 | J | — | 85,875 | — | Form 4 |
| AVR | L1 Capital Pty Ltd | 10% Owner | 08/28/2026 | Verkauf | 8.83 | 7,800 | 68,874 | Form 4 |
| AII | Ritchie Robert C | Chief Executive Officer | 08/28/2026 | Verkauf | 26.50 | 6,000 | 159,000 | Form 4 |
| AMRC | Sakellaris George P | Chief Executive Officer | 08/28/2026 | Kauf | 22.13 | 3,000 | 66,390 | Form 4 |
| ABNB | Chesky Brian | CEO and Chairman | 08/28/2026 | Schenkung | — | 76,500 | — | Form 4 |
| ABNB | Blecharczyk Nathan | Chief Strategy Officer | 08/28/2026 | Verkauf | 191.20 | 11,945 | 2,283,889 | Form 4 |
| ABNB | Blecharczyk Nathan | Chief Strategy Officer | 08/28/2026 | Verkauf | 190.58 | 45,215 | 8,617,143 | Form 4 |
| ABNB | Blecharczyk Nathan | Chief Strategy Officer | 08/28/2026 | Wandlung | — | 57,160 | — | Form 4 |
| AFRM | Linford Michael | Chief Operating Officer | 08/28/2026 | Verkauf | 90.01 | 79,219 | 7,130,502 | Form 4 |
| AFRM | Linford Michael | Chief Operating Officer | 08/28/2026 | Optionsausübung | 5.39 | 79,219 | 426,990 | Form 4 |
| AFCG | Tannenbaum Leonard M | Director | 08/28/2026 | Kauf | 3.53 | 65,752 | 232,105 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 2,400 | 24,480 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 2,200 | 22,440 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 400 | 4,080 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 800 | 8,160 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 4,100 | 41,820 | Form 4 |
| AXICY | Batista de Lima Filho Pedro | Director | 08/28/2026 | Verkauf | 10.20 | 7,700 | 78,540 | Form 4 |
| AVNW | Croke Gary | SVP of Product and Innovation | 08/28/2026 | Zuteilung | — | 1,208 | — | Form 4 |
| AVNW | Smith Pete A | President and CEO | 08/28/2026 | Zuteilung | — | 23,357 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).